查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1322229

DNA 修復藥物市場（藥物類型：PARP 抑製劑、烷化劑等；劑型：片劑、膠囊和注射劑）- 全球行業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

DNA Repair Drugs Market (Drug Type: PARP Inhibitors, Alkylating Agents, and Others; and Dosage Form: Tablets, Capsules, and Injectable) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

DNA 修復藥物市場 - 報告範圍

TMR 關於全球 DNA 修復藥物市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球 DNA 修復藥物的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。該報告還提供了2023年至2031年全球DNA修復藥物市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領袖和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解 DNA 修復藥物市場。

該報告深入研究了全球 DNA 修復藥物市場的競爭格局。全球 DNA 修復藥物市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了描述。公司概述、財務狀況、最新發展和 SWOT 是本報告中介紹的全球 DNA 修復藥物市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設和研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 技術進步
  • 全球主要國家的疾病患病率和發病率
  • 管道分析
  • 按地區/全球划分的監管情景
  • COVID-19 大流行對行業的影響（價值鍊和短期/中期/長期影響）

第 6 章：全球市場分析與預測：按藥物類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按藥物類型，2017-2031
    • PARP抑製劑
    • 烷基化劑
    • 其他
  • 市場吸引力分析：按藥品類型

第 7 章：全球市場分析與預測：按劑型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按劑型，2017-2031
    • 乳癌
    • 卵巢癌
    • 肺癌
    • 頭頸癌
    • 其他
  • 市場吸引力分析：按劑型

第 8 章：全球市場分析與預測：按劑型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按劑型，2017-2031
    • 平板電腦
    • 膠囊
    • 注射劑
  • 市場吸引力分析：按劑型

第 9 章：全球市場分析與預測：按配銷通路

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：2017-2031年按配銷通路
    • 零售藥店
    • 醫院藥房
    • 網上藥店
  • 市場吸引力分析：按配銷通路

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（按公司層級和規模）
  • 市場佔有率分析：按公司分類（2021 年）
  • 公司簡介
    • AstraZeneca plc
    • Clovis Oncology
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Novartis AG
    • Johnson & Johnson
    • Bristol Myers Squibb Company
    • Onxeo
Product Code: TMRGL77165

DNA Repair Drugs Market - Scope of Report

TMR's report on the global DNA Repair Drugs Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global DNA Repair Drugs Market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global DNA Repair Drugs Market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the DNA Repair Drugs Market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global DNA Repair Drugs Market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global DNA Repair Drugs Market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global DNA Repair Drugs Market.

The report delves into the competitive landscape of the global DNA Repair Drugs Market. Key players operating in the global DNA Repair Drugs Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global DNA Repair Drugs Market profiled in this report.

Key Questions Answered in Global DNA Repair Drugs Market Report:

  • What is the sales/revenue generated by mobile photo printer across all regions during the forecast period?
  • What are the opportunities in the global DNA Repair Drugs Market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

DNA Repair Drugs Market - Research Objectives and Research Approach

The comprehensive report on the global DNA Repair Drugs Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global DNA Repair Drugs Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global DNA Repair Drugs.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global DNA Repair Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global DNA Repair Drugs Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
  • 5.3. Pipeline Analysis
  • 5.4. Regulatory Scenario by Region/Globally
  • 5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global DNA Repair Drugs Market Analysis and Forecast, by Drug Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Drug Type, 2017-2031
    • 6.3.1. PARP Inhibitors
    • 6.3.2. Alkylating Agents
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Drug Type

7. Global DNA Repair Drugs Market Analysis and Forecast, by Dosage Form

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 7.3.1. Breast Cancer
    • 7.3.2. Ovarian Cancer
    • 7.3.3. Lung Cancer
    • 7.3.4. Head and Neck Cancer
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Dosage Form

8. Global DNA Repair Drugs Market Analysis and Forecast, by Dosage Form

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 8.3.1. Tablets
    • 8.3.2. Capsules
    • 8.3.3. Injectables
  • 8.4. Market Attractiveness Analysis, by Dosage Form

9. Global DNA Repair Drugs Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 9.3.1. Retail Pharmacies
    • 9.3.2. Hospital Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global DNA Repair Drugs Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America DNA Repair Drugs Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Drug Type, 2017-2031
    • 11.2.1. PARP Inhibitors
    • 11.2.2. Alkylating Agents
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 11.3.1. Breast Cancer
    • 11.3.2. Ovarian Cancer
    • 11.3.3. Lung Cancer
    • 11.3.4. Head and Neck Cancer
    • 11.3.5. Others
  • 11.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 11.4.1. Tablets
    • 11.4.2. Capsules
    • 11.4.3. Injectables
  • 11.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.5.1. Retail Pharmacies
    • 11.5.2. Hospital Pharmacies
    • 11.5.3. Online Pharmacies
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Drug Type
    • 11.7.2. By Dosage Form
    • 11.7.3. By Dosage Form
    • 11.7.4. By Distribution Channel
    • 11.7.5. By Country/Sub-region

12. Europe DNA Repair Drugs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Drug Type, 2017-2031
    • 12.2.1. PARP Inhibitors
    • 12.2.2. Alkylating Agents
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 12.3.1. Breast Cancer
    • 12.3.2. Ovarian Cancer
    • 12.3.3. Lung Cancer
    • 12.3.4. Head and Neck Cancer
    • 12.3.5. Others
  • 12.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 12.4.1. Tablets
    • 12.4.2. Capsules
    • 12.4.3. Injectables
  • 12.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.5.1. Retail Pharmacies
    • 12.5.2. Hospital Pharmacies
    • 12.5.3. Online Pharmacies
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Drug Type
    • 12.7.2. By Dosage Form
    • 12.7.3. By Dosage Form
    • 12.7.4. By Distribution Channel
    • 12.7.5. By Country/Sub-region

13. Asia Pacific DNA Repair Drugs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Drug Type, 2017-2031
    • 13.2.1. PARP Inhibitors
    • 13.2.2. Alkylating Agents
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 13.3.1. Breast Cancer
    • 13.3.2. Ovarian Cancer
    • 13.3.3. Lung Cancer
    • 13.3.4. Head and Neck Cancer
    • 13.3.5. Others
  • 13.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 13.4.1. Tablets
    • 13.4.2. Capsules
    • 13.4.3. Injectables
  • 13.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.5.1. Retail Pharmacies
    • 13.5.2. Hospital Pharmacies
    • 13.5.3. Online Pharmacies
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Drug Type
    • 13.7.2. By Dosage Form
    • 13.7.3. By Dosage Form
    • 13.7.4. By Distribution Channel
    • 13.7.5. By Country/Sub-region

14. Latin America DNA Repair Drugs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Drug Type, 2017-2031
    • 14.2.1. PARP Inhibitors
    • 14.2.2. Alkylating Agents
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 14.3.1. Breast Cancer
    • 14.3.2. Ovarian Cancer
    • 14.3.3. Lung Cancer
    • 14.3.4. Head and Neck Cancer
    • 14.3.5. Others
  • 14.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 14.4.1. Tablets
    • 14.4.2. Capsules
    • 14.4.3. Injectables
  • 14.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.5.1. Retail Pharmacies
    • 14.5.2. Hospital Pharmacies
    • 14.5.3. Online Pharmacies
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Drug Type
    • 14.7.2. By Dosage Form
    • 14.7.3. By Dosage Form
    • 14.7.4. By Distribution Channel
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa DNA Repair Drugs Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Drug Type, 2017-2031
    • 15.2.1. PARP Inhibitors
    • 15.2.2. Alkylating Agents
    • 15.2.3. Others
  • 15.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 15.3.1. Breast Cancer
    • 15.3.2. Ovarian Cancer
    • 15.3.3. Lung Cancer
    • 15.3.4. Head and Neck Cancer
    • 15.3.5. Others
  • 15.4. Market Value Forecast, by Dosage Form, 2017-2031
    • 15.4.1. Tablets
    • 15.4.2. Capsules
    • 15.4.3. Injectables
  • 15.5. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.5.1. Retail Pharmacies
    • 15.5.2. Hospital Pharmacies
    • 15.5.3. Online Pharmacies
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Drug Type
    • 15.7.2. By Dosage Form
    • 15.7.3. By Application
    • 15.7.4. By Distribution Channel
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. AstraZeneca plc
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Clovis Oncology
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. GlaxoSmithKline plc
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Pfizer Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Merck & Co. Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Novartis AG
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Johnson & Johnson
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Bristol Myers Squibb Company
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Onxeo
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 01: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 02: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 03: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 01: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 07: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 08: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 11: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 01: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 13: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 15: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 16: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 15: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 20: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 21: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
  • Table 15: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 24: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global DNA Repair Drugs Market Value Share, by Drug Type, 2022
  • Figure 03: Global DNA Repair Drugs Market Value Share, by Dosage Form, 2022
  • Figure 04: Global DNA Repair Drugs Market Value Share, by Distribution Channel, 2022
  • Figure 05: Global DNA Repair Drugs Market Value Share, by Region, 2022
  • Figure 06: Global DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 07: Global DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 08: Global DNA Repair Drugs Market Revenue (US$ Mn), by PARP Inhibitors, 2017-2031
  • Figure 09: Global DNA Repair Drugs Market Revenue (US$ Mn), by Alkylating Agents, 2017-2031
  • Figure 10: Global DNA Repair Drugs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 11: Global DNA Repair Drugs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 06: Global DNA Repair Drugs Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 07: Global DNA Repair Drugs Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 08: Global DNA Repair Drugs Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 09: Global DNA Repair Drugs Market Revenue (US$ Mn), by Ovarian Cancer, 2017-2031
  • Figure 08: Global DNA Repair Drugs Market Revenue (US$ Mn), by Breast Cancer, 2017-2031
  • Figure 09: Global DNA Repair Drugs Market Revenue (US$ Mn), by Lung Cancer, 2017-2031
  • Figure 08: Global DNA Repair Drugs Market Revenue (US$ Mn), by Head and Neck Cancer, 2017-2031
  • Figure 09: Global DNA Repair Drugs Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 16: Global DNA Repair Drugs Market Value Share Analysis, by Dosage Form, 2017-2031
  • Figure 17: Global DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 18: Global DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 19: Global DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 20: Global DNA Repair Drugs Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global DNA Repair Drugs Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: North America DNA Repair Drugs Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 24: North America DNA Repair Drugs Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 25: North America DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 26: North America DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 27: North America DNA Repair Drugs Market Value Share Analysis (US$ Mn), by Dosage Form, 2017-2031
  • Figure 28: North America DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 29: North America DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 30: North America DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 31: Europe DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Europe DNA Repair Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Europe DNA Repair Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Europe DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 35: Europe DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 36: Europe DNA Repair Drugs Market Value Share Analysis, by Dosage Form, 2017-2031
  • Figure 37: Europe DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 38: Europe DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 39: Europe DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 40: Asia Pacific DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Asia Pacific DNA Repair Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Asia Pacific DNA Repair Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Asia Pacific DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 44: Asia Pacific DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 45: Asia Pacific DNA Repair Drugs Market Value Share Analysis, by Dosage Form, 2017-2031
  • Figure 46: Asia Pacific DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 47: Asia Pacific DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 48: Asia Pacific DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 49: Latin America DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Latin America DNA Repair Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 51: Latin America DNA Repair Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 52: Latin America DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 53: Latin America DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 54: Latin America DNA Repair Drugs Market Value Share Analysis, by Dosage Form, 2017-2031
  • Figure 55: Latin America DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 56: Latin America DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 57: Latin America DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031
  • Figure 58: Middle East & Africa DNA Repair Drugs Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Middle East & Africa DNA Repair Drugs Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 60: Middle East & Africa DNA Repair Drugs Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Middle East & Africa DNA Repair Drugs Market Value Share Analysis, by Drug Type, 2022 and 2031
  • Figure 62: Middle East & Africa DNA Repair Drugs Market Attractiveness Analysis, by Drug Type, 2023-2031
  • Figure 63: Middle East & Africa DNA Repair Drugs Market Value Share Analysis, by Dosage Form, 2017-2031
  • Figure 64: Middle East & Africa DNA Repair Drugs Market Attractiveness Analysis, by Dosage Form, 2023-2031
  • Figure 65: Middle East & Africa DNA Repair Drugs Market Value Share Analysis, by Distribution Channel, 2022 and 2031
  • Figure 66: Middle East & Africa DNA Repair Drugs Market Attractiveness Analysis, by Distribution Channel, 2023-2031